tiprankstipranks
Mckesson Corp. (CH:MCK)
:MCK
Switzerland Market

McKesson (MCK) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

MCK Analyst Ratings

Strong Buy
13Ratings
Strong Buy
10 Buy
3 Hold
0 Sell
Based on 13 analysts giving stock ratings to
McKesson
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MCK Stock 12 Month Forecast

Average Price Target

Based on 13 Wall Street analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is CHF793.46 with a high forecast of CHF867.57 and a low forecast of CHF678.79. The average price target represents a change from the last price of .
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
Highest Price TargetCHF867.57Average Price TargetCHF793.46Lowest Price TargetCHF678.79
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:MCK
Morgan Stanley
Morgan Stanley
CHF784.83
Buy
Reiterated
08/25/26
McKesson Buy Rating Reiterated as Precision Medicine Acquisition Expands Oncology Strategy; Price Target Maintained at $977
Bank of America Securities Analyst forecast on CH:MCK
Bank of America Securities
Bank of America Securities
CHF843.47
Buy
Reiterated
08/25/26
McKesson Buy Rating Reiterated as Precision Medicine Acquisition Strengthens Oncology Platform; $1050 Price Target Unchanged
William Blair Analyst forecast on CH:MCK
William Blair
William Blair
Buy
Reiterated
08/25/26
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NASDAQ: NRXP) and McKesson (NYSE: MCK)
RBC Capital Analyst forecast on CH:MCK
RBC Capital
RBC Capital
CHF678.79
Hold
Initiated
08/19/26
McKesson initiated with a Sector Perform at RBC CapitalMcKesson initiated with a Sector Perform at RBC Capital
Barclays
CHF743.06CHF803.3
Buy
Reiterated
08/18/26
Barclays Sticks to Its Buy Rating for McKesson (MCK)
Wells Fargo Analyst forecast on CH:MCK
Wells Fargo
Wells Fargo
CHF652.28CHF749.48
Hold
Assigned
08/11/26
Wells Fargo Releases a Hold Rating on McKesson (MCK)
J.P. Morgan Analyst forecast on CH:MCK
J.P. Morgan
J.P. Morgan
CHF837.04
Buy
Reiterated
08/10/26
McKesson (MCK) Gets a Buy from J.P. Morgan
Citi
CHF803.3
Buy
Reiterated
08/10/26
Citi Keeps Their Buy Rating on McKesson (MCK)
Robert W. Baird Analyst forecast on CH:MCK
Robert W. Baird
Robert W. Baird
CHF767.16CHF815.35
Buy
Reiterated
08/06/26
McKesson price target raised to $1,015 from $955 at BairdMcKesson price target raised to $1,015 from $955 at Baird
TD Cowen
CHF794.47CHF808.12
Buy
Assigned
08/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS
CHF843.47CHF867.57
Buy
Reiterated
08/06/26
UBS Sticks to Its Buy Rating for McKesson (MCK)
Evercore ISI
CHF690.84CHF803.3
Buy
Reiterated
08/06/26
McKesson price target raised to $1,000 from $860 at Evercore ISIMcKesson price target raised to $1,000 from $860 at Evercore ISI
Mizuho Securities Analyst forecast on CH:MCK
Mizuho Securities
Mizuho Securities
CHF710.92CHF726.99
Hold
Reiterated
08/05/26
McKesson price target raised to $905 from $885 at MizuhoMcKesson price target raised to $905 from $885 at Mizuho
Deutsche Bank  Analyst forecast on CH:MCK
Deutsche Bank
Deutsche Bank
CHF781.61CHF702.89
Buy
Reiterated
05/08/26
McKesson price target lowered to $875 from $973 at Deutsche BankMcKesson price target lowered to $875 from $973 at Deutsche Bank
William O'Neil Analyst forecast on CH:MCK
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
Buy
Initiated
10/17/25
McKesson (MCK) Initiated with a Buy at William O'Neil
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:MCK
Morgan Stanley
Morgan Stanley
CHF784.83
Buy
Reiterated
08/25/26
McKesson Buy Rating Reiterated as Precision Medicine Acquisition Expands Oncology Strategy; Price Target Maintained at $977
Bank of America Securities Analyst forecast on CH:MCK
Bank of America Securities
Bank of America Securities
CHF843.47
Buy
Reiterated
08/25/26
McKesson Buy Rating Reiterated as Precision Medicine Acquisition Strengthens Oncology Platform; $1050 Price Target Unchanged
William Blair Analyst forecast on CH:MCK
William Blair
William Blair
Buy
Reiterated
08/25/26
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NASDAQ: NRXP) and McKesson (NYSE: MCK)
RBC Capital Analyst forecast on CH:MCK
RBC Capital
RBC Capital
CHF678.79
Hold
Initiated
08/19/26
McKesson initiated with a Sector Perform at RBC CapitalMcKesson initiated with a Sector Perform at RBC Capital
Barclays
CHF743.06CHF803.3
Buy
Reiterated
08/18/26
Barclays Sticks to Its Buy Rating for McKesson (MCK)
Wells Fargo Analyst forecast on CH:MCK
Wells Fargo
Wells Fargo
CHF652.28CHF749.48
Hold
Assigned
08/11/26
Wells Fargo Releases a Hold Rating on McKesson (MCK)
J.P. Morgan Analyst forecast on CH:MCK
J.P. Morgan
J.P. Morgan
CHF837.04
Buy
Reiterated
08/10/26
McKesson (MCK) Gets a Buy from J.P. Morgan
Citi
CHF803.3
Buy
Reiterated
08/10/26
Citi Keeps Their Buy Rating on McKesson (MCK)
Robert W. Baird Analyst forecast on CH:MCK
Robert W. Baird
Robert W. Baird
CHF767.16CHF815.35
Buy
Reiterated
08/06/26
McKesson price target raised to $1,015 from $955 at BairdMcKesson price target raised to $1,015 from $955 at Baird
TD Cowen
CHF794.47CHF808.12
Buy
Assigned
08/06/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS
CHF843.47CHF867.57
Buy
Reiterated
08/06/26
UBS Sticks to Its Buy Rating for McKesson (MCK)
Evercore ISI
CHF690.84CHF803.3
Buy
Reiterated
08/06/26
McKesson price target raised to $1,000 from $860 at Evercore ISIMcKesson price target raised to $1,000 from $860 at Evercore ISI
Mizuho Securities Analyst forecast on CH:MCK
Mizuho Securities
Mizuho Securities
CHF710.92CHF726.99
Hold
Reiterated
08/05/26
McKesson price target raised to $905 from $885 at MizuhoMcKesson price target raised to $905 from $885 at Mizuho
Deutsche Bank  Analyst forecast on CH:MCK
Deutsche Bank
Deutsche Bank
CHF781.61CHF702.89
Buy
Reiterated
05/08/26
McKesson price target lowered to $875 from $973 at Deutsche BankMcKesson price target lowered to $875 from $973 at Deutsche Bank
William O'Neil Analyst forecast on CH:MCK
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
Buy
Initiated
10/17/25
McKesson (MCK) Initiated with a Buy at William O'Neil
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering McKesson

3 Months
Erin WrightMorgan Stanley
Success Rate
19/23 ratings generated profit
83%
Average Return
+6.56%
Copying Erin Wright's trades and holding each position for 3 Months would result in 82.61% of your transactions generating a profit, with an average return of +6.56% per trade.
1 Year
Erin WrightMorgan Stanley
Success Rate
23/23 ratings generated profit
100%
Average Return
+25.51%
Copying Erin Wright's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.51% per trade.
2 Years
Erin WrightMorgan Stanley
Success Rate
23/23 ratings generated profit
100%
Average Return
+35.05%
Copying Erin Wright's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MCK Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
17
21
23
23
24
Hold
6
4
3
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
25
26
25
28
In the current month, MCK has received 24 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MCK average Analyst price target in the past 3 months is 793.46.
Each month's total comprises the sum of three months' worth of ratings.

MCK Financial Forecast

MCK Earnings Forecast

Next quarter’s earnings estimate for MCK is CHF8.59 with a range of CHF8.44 to CHF8.85. The previous quarter’s EPS was CHF7.96. MCK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.
Next quarter’s earnings estimate for MCK is CHF8.59 with a range of CHF8.44 to CHF8.85. The previous quarter’s EPS was CHF7.96. MCK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Sales Forecast

Next quarter’s sales forecast for MCK is CHF88.12B with a range of CHF87.24B to CHF88.83B. The previous quarter’s sales results were CHF84.49B. MCK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.
Next quarter’s sales forecast for MCK is CHF88.12B with a range of CHF87.24B to CHF88.83B. The previous quarter’s sales results were CHF84.49B. MCK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MCK has Performed in-line its overall industry.

MCK Stock Forecast FAQ

What is CH:MCK’s average 12-month price target, according to analysts?
Based on analyst ratings, Mckesson Corp.’s 12-month average price target is 793.46.
    What is CH:MCK’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:MCK, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Mckesson Corp. a Buy, Sell or Hold?
        Mckesson Corp. has a consensus rating of Strong Buy, which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Mckesson Corp.’s share price target?
          The average share price target for Mckesson Corp. is 793.46. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF867.57 ,and the lowest forecast is CHF678.79. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Mckesson Corp.?
            Mckesson Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
              How can I buy shares of Mckesson Corp.?
              To buy shares of CH:MCK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.